उत्पाद वर्णन
Dabigatran etexilate mesilate Tablet is a venerable and formidable anticoagulant designed for adults requiring prevention of stroke and systemic embolism in non-valvular atrial fibrillation, as well as for treating and preventing deep vein thrombosis and pulmonary embolism. With strengths of 110 mg and 150 mg, its lustrous white to off-white, capsule-shaped tablets offer savings to patients seeking affordable therapy without sacrificing quality. The scarce availability of such WHO-GMP-regulated medicines underscores their value and reliability. Packaged securely in blister strips, they maintain efficacy for 24 months when stored correctly.
Key Advantages and Features of Dabigatran etexilate mesilate Tablet
Dabigatran etexilate mesilate Tablet stands out with primary competitive advantages such as consistent quality assurance, WHO-GMP certification, and robust allopathic formulation. It is crafted from high-quality materials, ensuring therapeutic reliability. Its innovative direct thrombin inhibition mechanism reduces stroke risk in atrial fibrillation while also addressing DVT and pulmonary embolism. Easy oral administration and effective blister packaging further enhance its safety and longevity, making it a preferred choice in modern anticoagulant therapy.
Market Reach, Certifications, and Global Exchange for Dabigatran etexilate mesilate Tablet
The main domestic market for Dabigatran etexilate mesilate Tablet is India, where it enjoys widespread usage and distribution through reliable goods transport networks. This product boasts vital regulatory certifications, notably WHO-GMP approval, ensuring international quality standards. Main export markets include regions in Asia, Africa, and the Middle East, facilitated by efficient transport services and exchange systems, making it a trusted pharmaceutical for global healthcare providers and major distributors alike.
FAQs of Dabigatran etexilate mesilate Tablet:
Q: How should Dabigatran etexilate mesilate Tablet be taken for best results?
A: Dabigatran etexilate mesilate Tablet should be taken orally, with or without food, as directed by your physician. Dosage depends on your medical condition and response to treatment.
Q: What are the primary benefits of using Dabigatran etexilate mesilate Tablet?
A: This anticoagulant efficiently prevents stroke and systemic embolism in non-valvular atrial fibrillation, while also helping treat and prevent deep vein thrombosis and pulmonary embolism.
Q: When is Dabigatran etexilate mesilate Tablet contraindicated?
A: The tablet is contraindicated in patients with active bleeding, hypersensitivity to dabigatran, and severe renal impairment.
Q: Where should Dabigatran etexilate mesilate Tablets be stored for optimal shelf life?
A: Store Dabigatran etexilate mesilate Tablets in a cool, dry place below 30C, away from light and moisture, to ensure their full 24-month shelf life.
Q: What certifications ensure the quality of Dabigatran etexilate mesilate Tablet?
A: The tablets are manufactured in WHO-GMP-approved facilities, guaranteeing high standards of quality and safety for both domestic and export markets.